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Rabbit blood leukocytes  ~ contain no detectable preformed pyrogen (4)  and 
produce much less pyrogen than exudate leukocytes (about 1/50)  when incu- 
bated  in 0.15  ~  NaC1  (4).  3 After phagocytosis  (5)  or  exposure  to  endotoxin 
(6),  3 on the other hand, they produce about the same or even greater amounts 
of pyrogen than exudate leukocytes. These findings suggest that blood leuko- 
cytes must be "activated" to release pyrogen in 0.15 ~  NaC1, and that activa- 
tion of blood leukocytes automatically takes place after phagocytosis or expo- 
sure to endotoxin. The following experiments deal with the process of activation 
and the presence of an activating factor in acute peritoneal exudates. 
Materials and Methods 
The procedures used to exclude exogenous  pyrogens (7), to prepare suspensions of leuko- 
cytes from both rabbit blood (4) and acute peritoneal exudates (7), to generate pyrogen from 
the cells (7), to assay the amount of pyrogen released (7, 8), and to measure the cellular 
contents and fluid concentrations of Na and K (5, 9) and the fuid concentration of Ca (5, 9) 
and of protein  (7) have all been previously described. Endotoxin (lipopolysaccharide  B from 
Escherichia coli 011 l:B4) was purchased from Difco Laboratories, Detroit, Mich., and cyclo- 
heximide (Acti-dione), puromycin dihydrochloride, and acfinomycin D were obtained from 
Nutritional Biochemicals Corp., Cleveland, Ohio. 
* This study was supported by grants from the United States Public Health Service (AI 
03772-05) and the Life Insurance Medical Research Fund. 
Predoctoral  trainee,  United States  Public  Health  Service Training Grant ST01 GM 
00339. 
§ Present address: Tyco Laboratories, Inc., Waltham, Mass. 
I[ Present address:  Department of  Medicine, Western  Reserve  University,  Cleveland, 
Ohio. 
** Present address: Department of Physiology, Harvard  Medical School, Boston, Mass. 
1 Since rabbit monocytes, as well as granulocytes, are capable of generating pyrogen (1-3), 
the term leukocyte will be used to include both types of cells, there having been no attempt 
to distinguish between them in these experiments. 
2  Berlin, R. D., and W. B. Wood, Jr. Unpublished observations. 
3  Moore, D. M., and W. B. Wood, Jr. Unpublished observations. 
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RESULTS 
Evolution of Acute Peritoneal Exudate.--To  study the in vivo conditions that 
accompany  the  accumulation  of  detectable  amounts  of  pyrogen  in  acute 
peritoneal exudates, rabbits were injected intraperitoneally in the usual manner 
with 400 ml of glycogen-sMine (7) and were sacrificed at intervals of 1, 4, 8, 12, 
and 18 hr. The results of the analyses performed at each interval are summarized 
in Table I. Pyrogen could not be detected in i ml doses of the peritoneal exudate 
until  (a)  considerable time had elapsed  (> 8 hr),  (b)  the protein concentration 
had become relatively high (about 0.5 g per 100 ml), and (c) the cell count had 
exceeded  1 X  106 per ml. As anticipated,  the concentration of K  in the fluid, 
after the first hour, was approximately that of plasma (about 5 meq per liter); 
whereas  total  Ca rose somewhat more slowly (presumably because of binding 
TABLE I 
Release of Endogenous Pyrogen* during Evolution of Sterile Peritoneal Exudate  Induced  by 
Glycogen-Saline~ 
Time  Volume  Cell count  Protein  K  Ca  Pyrogen 
hr  ml  106 ml  g/100 ml  meq/liter  meq/liter  FI12o/ml 
1  405  <1.0  0.14  3.7  0.7  1.1 
4  340  <1.0  0.14  4.8  1.6  1.4 
8  260  <1.0  0.19  4.1  2.7  0.8 
12  130  7.5  0.46  5.2  3.4  10.0 
18  120  12.2  0.76  5.6  4.2  10.1 
* The pyrogen  released into  the exudate  fluid produced  fevers characteristic  of endoge- 
nous pyrogen and was not affected by endotoxin tolerance (6). 
400 ml of 0.1% glycogen (w/v)  in 0.15 M pyrogen-free NaC1 injected intraperltoneally. 
All recorded values represent averages from fluids of 3 rabbits sacrificed at each time interval. 
to  protein)  but  eventually  reached  levels  to  be  expected  from  equilibration 
with free plasma Ca  ++. The release of pyrogen that occurred after 12 hr clearly 
indicated  that the leukocytes, which had originally come from the blood,  had 
somehow become activated  in  the  exudate  and,  once activated,  were able  to 
release pyrogen in the presence of physiological concentrations of K + and  Ca  ++. 
Factors  that influence  the  release  of pyrogen under  these  conditions  are  dis- 
cussed below (see section on Generation of Pyrogen in Exudate Fluid). 
Activator in Exudate Fluid.--Although  early peritoneal  exudate fluid  (4 hr) 
contains  no detectable  pyrogen in doses of 1 ml  (Table  I),  4 it does contain  a 
factor that activates blood leukocytes and "superactivates ''5 exudate leukocytes 
(Table II). The activation factor is composed of a  heat labile  macromolecular 
4 FI120 values below 3.0 are not significant (8, 9). 
5  The  term  superactivate  is used  because  exudate  leukocytes  are  already  activated  as 
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component and a heat stable dialyzable cofactor (Table III), which are readily 
separated  by Sephadex  G-50 sieve chromatography3 The dialyzable cofactor 
can be replaced by a  suitable inorganic buffer (phosphate), as shown in Table 
IV. The nondialyzable macromolecular component behaves like a  protein and 
is  readily inactivated by  treatment with  mercaptoethanol,  p-chloromercuri- 
benzoate, or trypsin (Table V). 
Activating  Properties  of Subpyrogenic  Quantities  of Endotoxin.--Incubation 
TABLE II 
Effect of Exudate  Fluid  Activator on Subsequent Release of Pyrogen from Blood and Exudate 
Leukocytes in 0.15 M NaCI 
Source of cells  Prior treatment of ceils  Pyrogen released in  0.15 M  NaCI* 
% 
Exudate  None  100 
Blood*  None  2 
Blood*  Incubated in exudate fluid§  98 
Exudate  Incubated in exndate fluid§  300 
* During incubation at 37°C for 1 hr. 
:~ From buffy coat. 
§ 3.5 X  10  s cells in 10 ml at 37°C for 4 hr. 
TABLE III 
Cofactor Requirement of Activator in Exudate  Fluid 
Activation  medium*  Pyrogen released (FI120)~: 
Unheated exudate fluid +  0.15 M NaCI§  6.5  (-4-0.6) 
Dialyzed exudate fluid -4- 0.15 ~ NaCI§  0.6  (-4-0.5) 
Heatedll exudate fluid +  0.15 M NaCI§  0.7  (-4-0.1) 
Dialyzed exudate fluid +  heated exudate fluid§  9.3  (-4-1.8) 
* In which exudate cells were first incubated for 4 hr at 37°C. 
By 5 X  106 cells incubated for 1 hr at 37°C in 0.15 M  NaCI; FI120 value, average febrile 
response in 3 rabbits ±  standard  error of mean. 
§ 10 ml of each per 3.5 X  10  s cells; final concentration of K  + adjusted to 5 meq per liter. 
[I At 100°C for 30 min. 
of exudate leukocytes with amounts of E.  coli endotoxin that are themselves 
nonpyrogenic  causes the cells to produce more than the usual amount of pyrogen 
when  incubated in  0.15  ~[  NaC1  (Table VI).  This  superactivation effect  is 
indistinguishable from  that  caused  by  the  activator  in  acute  exudate  fluid 
(Tables II-V). Not  only does  it have approximately the  same pH  optimum 
(cf.  Tables IV and VII), but it is also nullified by the  same amount of heat 
and the same concentration of mercaptoethanol (see Tables III and V). Besides 
superactivating exudate leukocytes, subpyrogenic doses of endotoxin activate 
blood leukocytes, and the exudate fluid activator does the same.  3 182  PATtIOGENESIS  OF  FEVER.  XVIII 
Kinetics of Superactivation Process.--As shown in Fig.  1, the superactivating 
effect of the exudate fluid activator on exudate leukocytes is readily detectable 
within  30  rain  but  continues  to  increase  for  several hours.  In  contrast,  heat- 
inactivated  exudate  fluid  fails  to  superactivate  the  cells. 
TABLE IV 
pH-Dependence of Activator in Exudate Fluid 
Treatment of exudate fluid*  pH  Pyrogen released  (FI12~)$ 
None  8.0  10.9  (4-0.6) 
Dialyzed vs. unbuffered NaCI§  6.0  0.6  (4-0.3) 
Dialyzed vs. buffered NaC1H  6.0  0.7  (4-0.3) 
........  7.0  9.1  (4-0.8) 
........  8.0  14.2  (4-0.9) 
* In which exudate cells were incubated as described in footnote § of Table II. 
:~ By  1.7  X  107 cells incubated for  1 hr at 37°C in 0.15  M NaC1; average response of 3 
rabbits  4- standard  error of mean. 
§ 0.15 M NaCl. 
I] 0.15 ~  NaCI +  0.01 ~  phosphate buffer. 
TABLE V 
Inactivation of Macromolecular Component of Activator Factor in Exudate Fluid 
Treatment of exudate fluid*  Pyrogen released  FIl~0$ 
Control§ 
2-Mercaptoethanol (0.6 ~) § 
"  (1.2 M)§ 
p-Chloromercuribenzoate (0.02 M)§ 
Trypsin (1 mg per ml) § 
Incubated at 37°C for 18 hr 
9.0  (4-1.1) 
3.6  (4-0.4) 
0.8  (4-0.6) 
0.1  (4-0.1) 
0.6  (4-0.1) 
11.9  (+1.0) 
* In which exudate cells were incubated as in Table II. 
z~ By 5 X  106 exudate cells incubated for 1 hr at 37°C in 0.15 M NaC1; average response -4- 
standard error of mean. 
§ Fluid was incubated for 1 hr at 37°C, dialyzed at 4°C against 0.15 ~  NaC1  (to remove 
inactivating reagent when dialyzable) and was finally mixed with an equal volume of heated 
exudate fluid to replace the necessary dialyzable factor (see text). 
Cellular Na and K.--Measurements  of cellular Na  and  K  were done  before 
and  after  superactivation  of  exudate  cells,  and  no  correlation  with  pyrogen 
productivity in 0.15 M NaC1 was demonstrated. 
Generation  of Pyrogen in Exudate  Fluid.--When  exudate  leukocytes  are  in- 
cubated  in  early  (4 hr)  exudate fluid in vitro,  only small amounts  of pyrogen 
are gradually released from the cells (cf. Table VIII and Fig.  1 in reference 9). 
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is released at all (Table viii). This is presumably due to the inhibitory effect 
of the K + and Ca  ++ (10) in the exudate fluid. If, on the other hand, the virtually 
anaerobic conditions of the in vivo exudate are simulated in an in vitro experi- 
ment,  the  release  of  pyrogen is  significantly enhanced  (Table IX).  Thus  it 
TABLE VI 
Comparison of Primary Pyrogenicity and Actzvating Effect oJ Endotoxin 
Endotoxin  Primary pyrogenicity  Activating effect 
tzg  FI12o*  FIl~o$ 
0.1  17.0  13.2 
0.03  4.2  11.4 
0.01  2.0  9.6 
0.005  0.6  7.3 
0.001  0.2  4.7 
0.0005  0.3  4.2 
0.0  0.0  1.3 
* Endotoxin injected in 10 ml of heated  exudate fluid; FI120, average febrile response of 
2-4 rabbits. 
:~ Represents average pyrogen released from 20 X  106 exudate granulocytes incubated for 
1 hr in 0.15 M NaC1 after having been incubated for 4 hr in heated  exudate fluid (10 ml) 
containing endotoxin; FI120, average response of 3 rabbits. 
TABLE VII 
pH-Dependence of Endotoxin Activation 
pit of activation medium* 
After 4 hr. incubation 
At start  with cellst 
Pyrogen released (FI120) § 
6.0  6.0  1.3 (:k0.4) 
6.5  6.4  8.5 (:k0.4) 
7.0  6.7  11.9 (=1=0.9) 
* 0.15 M  NaC1 buffered with 0.01 M  phosphate containing 5 meq of K  + and 0.01 #g of endo- 
toxin/ml. 
:~ As in Table II. 
§ By 20 X 106 exudate cells after incubation  for 1 hr at 37°C in 0.15 ~ NaC1; FI120, average 
response of 4 rabbits :t: standard error of mean. 
seems  probable  that  both  the  presence  of  the  activator  and  the  anaerobic 
character of the exudate contribute to the in vivo release of pyrogen demon- 
strated in Table I. 
Evidence  that  Activation  Involves  Synthesis  of  Protein.--The  nature  and 
kinetics of the activation process suggest that it may involve the synthesis of 
new cellular proteins. In keeping with this possibility are the observations that 
both puromycin (1  >(  10  -4 ~I)  and cycloheximide (8.9)<  I0  -~ M)  block the 184  PATHOGENESIS  OF  FEVER.  XVIII 
activation  of  blood  leukocytes,  whether  induced  by  endotoxin  (Table  X)  or 
phagocytosis  (Table XI).  In addition,  endotoxin-induced  activation is blocked 
by  actinomycin  D  (1  X  10  .5  ~)  (Table  XII). 6 It  will  be  recalled  from  the 
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FIG. 1.  Kinetics of superactivation process.  The average amount of pyrogen produced by 
3.5  ;<  107 exudate cells incubated  (37°C) in 0.15 ~  NaC1 for I  hr is plotted on the ordinate, 
and  the  time  the cells  (3.5 X  10  s)  were preincubated  in  unheated  (O----e)  or heated 
(© .... O)  exudate  fluid  (10  ml)  is plotted  on  the abscissa.  The latter fluid was heated  at 
100°C for 30 min. The bars indicate 4- standard error of the mean. 
TABLE VIII 
Slow Generation of Pyrogen by Exudate Leukocytes d~ring Incubation in 4 Hr Exudate Fluid 
State of • hr exudate fluid  Incubation  (37°C) time  Pyrogen released 
]~r  FI120* 
Unheated  4  7.3  (4-2.1) 
Unheated  8  9.7  (4-1.7) 
Unheated  12  15.6  (4-3.3) 
Heated~  4  0.6 (4-0.3) 
Heated:~  8  0.7  (4-0.4) 
Heated*  12  0.3  (4-0.3) 
* From 3.5  X  l0  s cells in 10 ml of fluid; average response of 3 rabbits  4- standerd  error 
of mean. 
100°C for 30 min. 
preceding  paper  (9)  that  inhibition  of  protein  synthesis  by  puromycin  does 
not affect the release of pyrogen from exudate cells that are already activated. 
6 The increased yield resulting from the presence of actinomycin in the NaC1 medium (line 
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TABLE  IX 
More Rapid  Release of Pyrogen in 4 Hr Exudate Fluid during Anaerobic Incubation 
State of exudate fluid  Conditions of incubation*  Pyrogen released FIl20:~ 
Unheated  Aerobic  1.4 (4-0.6) 
Unheated  5% CO2-95¢7v N2  17.0  (q-1.4) 
Heated§  5% CO2-95% N2  1.4 (4-0.8) 
* For 2 hr at 37°C with continuous aeration. 
From 3.5 )<  l0  s cells in 10 ml of fluid  +  standard error of mean. 
§ 100°C for 30 rain. 
TABLE  X 
Blocking Effects of Puromycin and Cycloheximide on Activation of Blood Leukocytes 
by Endotoxin 
Incubation* media 
Activation period (0-2 hr)  Release period (2-4 hr) 
AT  ° (± sz)~ 
A.  Puromycin 
Blood-endotoxin§ 
Blood-endotoxin§ +  puromycinll 
0.15 M NaC1 
0.15 ~  NaC1 
1.13  (4-0.20) 
0.01  (4-0.01) 
(Controls) 
Blood alone (no activation) 
Blood-endotoxin§ 
0.15 M NaC1 
0.15  ~  NaC1  +  puromycinll 
0.04 (4-0.02) 
1.04 (4-0.16) 
B.  Cydoheximide 
Blood-endotoxin¶  0.15 •  NaC1 
Blood-endotoxin¶ +  cyclohex-  0.15 M NaC1 
imide** 
0.78  (±0.10) 
0.12  (4-0.04) 
(Controls) 
Blood alone (no activation)  0.15 ~  NaC1  0.05  (4-0.02) 
Blood-endotoxin¶  0.15  M  NaC1  +  cyclohex-  0.84  (4-0.08) 
imide** 
* 37oc. 
:~ Average response (C  °)  of 4  rabbits in A  and of 9-11  rabbits in B  to supernatant  (of 
release period) from 3.5 )<  107 leukocytes. 
§ 0.1 gg per l0  s leukocytes in whole blood (heparinized). 
11 lO-4 ~. 
¶0.025 ~g per l0  s leukocytes (new lot of endotoxin about 4 times as potent as lot used in 
all  of preceding experiments). 
** 8.9 X  10  -~ ~. 
DISCUSSION 
Blood leukocytes of rabbits differ from exudate leukocytes in two important 
respects: (a)  they contain virtually no detectable pyrogen in their cytoplasm 
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NaC1  (4)) Thus,  as far as pyrogen production  is concerned,  they appear  to be 
in a  dormant,  or unactivated, state. For such cells to produce pyrogen in saline, 
two  distinct  steps  are  necessary:  first,  they  must  become  activated;  and, 
secondly, they must be stimulated to release pyrogen. The saline release process, 
which  is highly sensitive  to  cationic  control,  requires  energy,  and  involves an 
TABLE XI 
Blocking Effects of Puromycin and Cydoheximide on Activation of Blood Leukocytes 
by Phagocytosis 
Treatment of cells during incubation* (activation and release)  AT  ° (:t= s~)$ 
A.  Puromyein 
Phagocytosis§  1.00  (4-0.06) 
Phagocytosis§ +  puromycin[[  0.07 (4-0.02) 
None (control)  0.05 (S=0.03) 
B.  Cycloheximide 
Phagocytosis§ 
Phagocytosis§, +  cycloheximlde¶ 
None (control) 
1.03  (=t=0.06) 
0.09 (:t=0.04) 
0.04  (=~0.02) 
* 4 hr at 37°C. 
:~ Average response  (C  °)  of 12-13  rabbits  for treatments  (and  4-6 rabbits  for controls) 
to supernatant from 3.5  X  107 blood leukocytes. 
§ Of heat-killed rough pneumococci  (strain  R36NC)  in whole blood  (heparinized);  mul- 
tiplicity of organisms to leukocytes was 50:1  (5). 
I110 -4 ~. 
¶8.9  X  10--5 M. 
TABLE XII 
Bbck~g Effect ~  A~mom~  D  on Act~at~n ~  Bbod  Leukocyt~  by Endotoxin 
Incubation*media 
Activation period (0--2 hr)  Release period (2-4 hr) 
AT  ° (:t= sx)~ 
Blood-endotoxin§  0.15 ~  NaC1 
Blood-endotoxin§ +  Actino- 0.15 ~  NaCI 
mycin D][ 
0.64 (4-0.05) 
0.20  (4-0.04) 
(Controls) 
Blood alone (no activation)  0.15 ~t NaC1  0.03  (4-0.03) 
Blood-endotoxin§  0.15 ~s NaC1 +  actinomyein D[I  1.09 (4-0.07) 
* 37°C. 
:~ Average response (C  °) of 7-15 rabbits to supernatant  (of release period) from 3.5 X  107 
leukocytes. 
§ 0.025 vg per 108 leukocytes in whole blood (heparlnized).  See footnote ¶, Table X. 
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increase in membrane permeability, has already been discussed in the preceding 
report (9). 
The activation step requires the synthesis of protein. The critical protein(s) 
synthesized may include an inactive precursor of the pyrogen molecule (pro- 
pyrogen) or an enzyme needed to convert it to active pyrogen (11). Evidence 
is  presented elsewhere that  neither is  synthesized during  the  release process 
(9) .7 
Only when pyrogen production is induced by incubation in  K-free saline, 
can the activation and release steps be clearly separated. Since blood leukocytes 
produce just as much pyrogen after phagocytosis as do exudate leukocytes (5), 
it is clear that both activation and release are stimulated by the ingestion of 
foreign particles. Similarly, in the endotoxin system, both processes are stimu- 
lated (6) 3 and hence are difficult to distinguish, unless the experiment is done 
in two stages (as in Table VI). 
When  unactivated  blood  granulocytes  participate  in  phagocytosis  or  are 
exposed to endotoxin, pyrogen production is inhibited by puromycin and by 
cycloheximide, since activation must occur before the pyrogen can be released. 
Actinomycin  D  also  inhibits  activation  of  blood  leukocytes  stimulated  by 
endotoxin. Similar findings have been obtained by Bodel, et al. (11) with activa- 
tion by phagocytosis and by etiocholanolone, and by Nordland et al. (12) with 
activation by phagocytosis and by endotoxin. When, on the other hand, exudate 
leukocytes or activated blood leukocytes (see Tables X  and XII) are incubated 
in 0.15 M NaC1, pyrogen production is not influenced by inhibitors of protein 
synthesis (9, 11), since the cells have already been activated. 
The presence in exudate fluid of the activator factor, Which (like endotoxin) 
induces both activation and  release, accounts for the production of pyrogen 
in acute exudates, despite the presence of K + and Ca  ++. The anaerobic condi- 
tions in the exudate also enhance the release process, perhaps by causing a rise 
in cationic content (particularly H +) of the cells (9). 
Just how the activator factor affects the cell is not known. Of interest is the 
fact that it is inactive in the pH range (<6.5) that  inhibits phagocytosis (13, 
14).  One  possibility  that  is  difficult  to  exclude is  that  the  macromolecular 
component of the exudate activator contains subpyrogenic quantities of endo- 
toxin. Although the activator factor in acute exudate fluid evidently contains 
an  essential  protein moiety, further studies  are  needed  to  define its  precise 
nature and mode of action. 
SUMMARY 
Blood  leukocytes,  in  contrast  to  exudate  leukocytes,  release  little  or  no 
pyrogen when incubated in 0.15 M NaC1 unless previously activated by exposure 
7 Hahn, H. H., S. F. Cheuk, D. S. Elfenbein, and W. B. Wood, Jr. Studies on the patho- 
genesis of fever. XIX.  Localization of pyrogen within granulocytes. To be published. 188  PATIXOGZENESIS  O~"  FEVER.  XVIII 
to  endotoxin or to  a  protein activator that  is present in acute  exudate fluid. 
The  activation  process,  which  also  occurs  during  phagocytosis,  involves  the 
synthesis of cellular protein, presumably related to the pyrogen molecule. Evi- 
dence  is presented  that generation  of pyrogen in sterile inflammatory lesions 
depends  on  both  the  activator  and  the  anaerobic  conditions in  the  exudate 
fluid. 
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